StockMarketWire.com - Oncology and rare disease focused Midatech Pharma said it had received funding of €6.6m from the Spanish government.

The funding would support the company' manufacturing facility in Bilbao.

It brought the total public financing available for the project to up to €8.5m, including previous grant and loan amounts recently approved by the Basque regional government.

The total manufacturing cost of the project was currently estimated at about €16m, subject to finalisation of a manufacturing strategy.

At 1:49pm: [LON:MTPH] Midatech Pharma Plc share price was +1p at 6.25p



Story provided by StockMarketWire.com